Atopic Dermatitis Treatment Market By Product (Calcineurin Inhibitors, Corticosteroids, Biologic Therapy, Immunosuppressants, and Others), By Route of Administration (Oral, Topical, Injectable), By End-Users (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, and Others), and By Region - Trends, Analysis and Forecast till 2034

With a projected growth rate of 5.30%, the market for treatments for atopic dermatitis is expected to reach US$ 10 billion by 2034, from a valuation of US$ 6 billion in 2024.

Aczema, another name for atopic dermatitis, is a chronic skin condition that causes redness, inflammation, and irritation. Emollients and moisturizers are frequently used daily treatments for atopic dermatitis by those who are infected. Atopic dermatitis is treated with a variety of products, including immunosuppressants, biologic therapy, corticosteroids, calcineurin inhibitors, and others.